Faculty Opinions recommendation of Sudden unexpected death after balloon valvuloplasty for congenital aortic stenosis.

Author(s):  
Larry Latson ◽  
Athar Qureshi
2010 ◽  
Vol 56 (23) ◽  
pp. 1939-1946 ◽  
Author(s):  
David W. Brown ◽  
Amy E. Dipilato ◽  
Erin C. Chong ◽  
Kimberlee Gauvreau ◽  
Doff B. McElhinney ◽  
...  

2015 ◽  
Vol 86 (5) ◽  
pp. 808-820 ◽  
Author(s):  
Alejandro Torres ◽  
Julie A. Vincent ◽  
Allen Everett ◽  
Scott Lim ◽  
Susan R. Foerster ◽  
...  

2016 ◽  
Vol 27 (5) ◽  
pp. 929-935 ◽  
Author(s):  
Bojana Radnic ◽  
Nemanja Radojevic ◽  
Jelena Vucinic ◽  
Natasa Duborija-Kovacevic

AbstractMost young patients with mild-to-moderate aortic stenosis show no symptoms, and sudden death appears only occasionally. We hypothesised that malignant ventricular arrhythmias could be responsible for the high incidence of sudden death in such patients. If multiple factors such as asymptomatic aortic stenosis in association with arrhythmia-provoking agents are involved, could it be sufficient to account for sudden unexpected death? In this study, eight cases of sudden death in young adults, with ages ranging from 22 to 36 years, who had never reported any symptoms that could be related to aortic stenosis, were investigated. Full autopsies were performed, and congenital aortic stenosis in all eight cases was confirmed. DNA testing for channelopathies was negative. Comprehensive toxicological analyses found an electrolyte imbalance, or non-toxic concentrations of amitriptyline, terfenadine, caffeine, and ethanol. Collectively, these results suggest that congenital asymptomatic aortic stenosis without cardiac hypertrophy in young adults is not sufficient to cause sudden death merely on its own; rather, an additional provoking factor is necessary. According to our findings, the provoking factor may be a state of physical or emotional stress, a state of electrolyte imbalance, or even taking a therapeutic dose of a particular drug.


2012 ◽  
Vol 81 (1) ◽  
pp. 90-95 ◽  
Author(s):  
Shiraz A. Maskatia ◽  
Henri Justino ◽  
Frank F. Ing ◽  
Matthew A. Crystal ◽  
Raphael J. Mattamal ◽  
...  

2014 ◽  
Vol 142 (1-2) ◽  
pp. 17-22 ◽  
Author(s):  
Vojislav Parezanovic ◽  
Milan Djukic ◽  
Ingo Daehnert ◽  
Ana Gligic ◽  
Igor Stefanovic ◽  
...  

Introduction. Balloon valvuloplasty (BVP) is one of the primary therapies for congenital aortic stenosis in children and adolescents. The aim of this interventional procedure is to gain time before possible surgical therapy (aortic valve replacement) until adulthood. Objective. The aim of this study was to evaluate the efficacy, safety and mid-term results of transcatheter BVP in children and adolescent in our Center. Methods. From 2004 to 2011, 50 patients, aged 18 days to 18 years (mean 6.3 years) underwent BVP. Retrospective analysis of the echocardiographic and hemodynamic parameters were performed before and after procedure, especially peak pressure gradient (PG) across the aortic valve, semiquantification of the aortic regurgitation (AR) after the BVP as well as the left ventricle dimensions and functions. Results. The mean peak PG in the whole group decreased from 74.80?27.72 mm Hg to 27.86?13.04 mm Hg (p<0.001) after BVP. In 39 patients (78%), residual PG was lower than 30 mm Hg just after dilation. At the end of follow-up period, 25 patients (50%) had PG above 50 mm Hg, measured by Doppler technique, and four of them underwent re-dilation. Eight patients (16%) had severe AR. During the follow-up period (12-80 months, mean 51 months), six patients (12%) were referred to cardiac surgeons for aortic valve replacement or Ross procedure. Conclusions. This retrospective study analyzes our first experience of BVP as primary therapy of the congenital aortic stenosis. The results confirmed that BVP effectively postponed the need for surgery in children and adolescents toward the adulthood.


2021 ◽  
pp. 1-7
Author(s):  
Benjamin C. Auld ◽  
Julia S. Donald ◽  
Naychi Lwin ◽  
Kim Betts ◽  
Nelson O. Alphonso ◽  
...  

Abstract Background: Balloon valvuloplasty and surgical aortic valvotomy have been the treatment mainstays for congenital aortic stenosis in children. Choice of intervention often differs depending upon centre bias with limited relevant, comparative literature. Objectives: This study aims to provide an unbiased, contemporary matched comparison of these balloon and surgical approaches. Methods: Retrospective analysis of patients with congenital aortic valve stenosis who underwent balloon valvuloplasty (Queensland Children’s Hospital, Brisbane) or surgical valvotomy (Royal Children’s Hospital, Melbourne) between 2005 and 2016. Patients were excluded if pre-intervention assessment indicated ineligibility to either group. Propensity score matching was performed based on age, weight, and valve morphology. Results: Sixty-five balloon patients and seventy-seven surgical patients were included. Overall, the groups were well matched with 18 neonates/25 infants in the balloon group and 17 neonates/28 infants in the surgical group. Median age at balloon was 92 days (range 2 days – 18.8 years) compared to 167 days (range 0 days – 18.1 years) for surgery (rank-sum p = 0.08). Mean follow-up was 5.3 years. There was one late balloon death and two early surgical deaths due to left ventricular failure. There was no significant difference in freedom from reintervention at latest follow-up (69% in the balloon group and 70% in the surgical group, p = 1.0). Conclusions: Contemporary analysis of balloon aortic valvuloplasty and surgical aortic valvotomy shows no difference in overall reintervention rates in the medium term. Balloon valvuloplasty performs well across all age groups, achieving delay or avoidance of surgical intervention.


Sign in / Sign up

Export Citation Format

Share Document